Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients

Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients

Patients with cancers that are sensitive to radiotherapy treatment and/or patients who have experienced severe acute/ late side effects to radiotherapy will be recruited to the study. Blood and/or matched tumour-normal tissue pairs will be collected. Blood and/or tissue samples will be processed and studied for genetic and biochemical markers that have potential to be used for predicting sensitivity to radiation.

Inclusion Criteria:

• Patients with severe side effects from radiotherapy
• Patients with a type of cancer that is associated with sensitivity to radiotherapy

Exclusion Criteria:

• Age of patient must be between 21 (inclusive) and 99 (exclusive)